Change does not happen overnight. Democracy does not suddenly collapse. It is a series of restrictive policies and an ...

In its first quarter 2025 investor letter, ClearBridge Value Strategy emphasized stocks such as Gilead Sciences, Inc. (NASDAQ:GILD). Gilead Sciences, Inc. (NASDAQ:GILD) is a biopharmaceutical company.

Gilead and Roche are continuing to lay off employees in California, with each company revealing a recent round of cuts through the state’s Worker Adjustment and Retraining Notification (WARN ...

Gilead Sciences (GILD), which belongs to the Zacks Medical - Biomedical and Genetics industry, could be a great candidate to consider. This HIV and hepatitis C drugmaker has seen a nice streak of ...

Here’s the first official series description for the spinoff, per Variety on Tuesday, April 1: “For these young women, growing up in Gilead is all they have ever known, having no tangible ...

Where “Heart Eyes” loses is in its ability to mix humor and horror. Others have done it (particularly “Scream”), but this ...

June’s fight to rescue her daughter, Hannah, and to stop Gilead once and for all, continues. “The Handmaid’s Tale” has returned to Hulu, with the first three episodes of its sixth and ...

The final season of 'The Handmaid's Tale' has arrived more than two years after the conclusion of the fifth season. Hear from ...

After years of demands from shareholders for another major deal, Gilead has made a spectacular move, sealing a deal to acquire cell therapy leader Kite for just under $12 billion. Gilead had been ...